273
Participants
Start Date
December 26, 2013
Primary Completion Date
December 24, 2014
Study Completion Date
December 24, 2014
Beclomethasone dipropionate breath-actuated inhaler
Beclomethasone dipropionate (BDP) breath-actuated inhaler (BAI) given in dosages of either 40 mcg/inhalation or 80 mcg/inhalation. Study drug was administered twice each day, in the morning and in the evening, after the completion of the asthma symptom score and the PEF measurements, in that order.
Placebo breath-actuated inhaler
Placebo was provided in matching breath-actuated inhaler (BAI) devices. The placebo devices were identical to the devices used to deliver active drug. Placebo was administered twice each day, in the morning and in the evening, after the completion of the asthma symptom score and the PEF measurements, in that order.
albuterol/salbutamol
Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period
Teva Investigational Site 12813, Huntington Beach
Teva Investigational Site 10944, Mission Viejo
Teva Investigational Site 10946, Orange
Teva Investigational Site 10963, Rolling Hills Estates
Teva Investigational Site 10960, San Diego
Teva Investigational Site 10973, San Diego
Teva Investigational Site 10975, San Jose
Teva Investigational Site 10948, Centennial
Teva Investigational Site 10958, Centennial
Teva Investigational Site 10957, Colorado Springs
Teva Investigational Site 12814, Sarasota
Teva Investigational Site 10962, Tallahassee
Teva Investigational Site 12809, Savannah
Teva Investigational Site 10947, Indianapolis
Teva Investigational Site 10943, Iowa City
Teva Investigational Site 10954, Baltimore
Teva Investigational Site 12940, Bethesda
Teva Investigational Site 10955, North Dartmouth
Teva Investigational Site 10941, Minneapolis
Teva Investigational Site 10970, Columbia
Teva Investigational Site 10968, Rolla
Teva Investigational Site 10972, Bozeman
Teva Investigational Site 12941, Missoula
Teva Investigational Site 10942, Bellevue
Teva Investigational Site 10959, Skillman
Teva Investigational Site 10945, Raleigh
Teva Investigational Site 12810, Cincinnati
Teva Investigational Site 10974, Sylvania
Teva Investigational Site 12805, Oklahoma City
Teva Investigational Site 12942, Oklahoma City
Teva Investigational Site 10951, Tulsa
Teva Investigational Site 10940, Lake Oswego
Teva Investigational Site 10952, Medford
Teva Investigational Site 10956, Portland
Teva Investigational Site 12939, Pittsburgh
Teva Investigational Site 12806, Orangeburg
Teva Investigational Site 12811, Knoxville
Teva Investigational Site 10969, Austin
Teva Investigational Site 12812, Boerne
Teva Investigational Site 10949, Dallas
Teva Investigational Site 10953, El Paso
Teva Investigational Site 12807, Houston
Teva Investigational Site 10950, New Braunfels
Teva Investigational Site 10961, San Antonio
Teva Investigational Site 12808, Waco
Teva Investigational Site 10967, Seattle
Teva Investigational Site 10964, Greenfield
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY